Details

Lactococcus lactis as a delivery system for surface displayed mimotopes of major peanut allergen Ara h 2
ID Lunder, Mojca (Author), ID Luzar, Jernej (Author), ID Ključevšek, Tim (Author), ID Berlec, Aleš (Author), ID Štrukelj, Borut (Author), ID Skerbinjek-Kavalar, Maja (Author), ID Koren, Ana (Author), ID Korošec, Peter (Author)

.pdfPDF - Presentation file, Download (2,78 MB)
MD5: 163E4CE0313A464645819AA159276AD5
URLURL - Source URL, Visit https://www.sciencedirect.com/science/article/pii/S0022175925001218 This link opens in a new window

Abstract
The prevalence of peanut allergy has been steadily increasing over the last decades. Among food allergies it shows the highest severity and is potentially fatal. Allergen Ara h 2 stands out as the main elicitor of allergic reactions. Research in the field of peanut immunotherapy still strives to improve the significant drawbacks of currently approved therapeutics. In this study we tested three epitope-like peptides as epitope-specific treatment. The epitope-like peptides (mimotopes) of major peanut allergen Ara h 2 were expressed as fusions with scaffold protein – lactococcal peptidoglycan binding domain of AcmA. Mimotope-decorated L. lactis and mimotope-AcmA fusion proteins were characterized. The mimotopes retained the ability to bind IgE from peanut-allergic patients' sera. They showed low basophil activation in peanut-allergic patients, except for mimotope DHPRYGP fused to AcmA suggesting its allergenic activity was partially preserved due to the highest similarity with Ara h 2 epitope. Mimotopes fused to AcmA can elicit T cell response; the increased secretion of IFN-γ suggests the shift of T cell immune response to non-allergic type 1. The use of recombinant L. lactis as a delivery system for surface displayed mimotopes represents a promising strategy that would enable delivery and expression of mimotopes on mucosal surfaces and at the same time beneficial immunomodulating properties.

Language:English
Keywords:peanut allergy, Ara h 2, Lactococcus lactis, mimotopes
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:FFA - Faculty of Pharmacy
Publication status:Published
Publication version:Version of Record
Year:2025
Number of pages:8 str.
Numbering:[article no.] 113921, Vol. 543
PID:20.500.12556/RUL-175626 This link opens in a new window
UDC:615.015.14:616-056.43
ISSN on article:1872-7905
DOI:10.1016/j.jim.2025.113921 This link opens in a new window
COBISS.SI-ID:247676163 This link opens in a new window
Publication date in RUL:06.11.2025
Views:69
Downloads:5
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Journal of immunological methods
Publisher:Elsevier Science
ISSN:1872-7905
COBISS.SI-ID:26129113 This link opens in a new window

Licences

License:CC BY-NC-ND 4.0, Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Link:http://creativecommons.org/licenses/by-nc-nd/4.0/
Description:The most restrictive Creative Commons license. This only allows people to download and share the work for no commercial gain and for no other purposes.

Secondary language

Language:Slovenian
Keywords:dostavni sistemi, alergeni, mimotopi, Lactococcus lactis

Projects

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P1-0420
Name:Napredna imunološka zdravila in celični pristopi v farmaciji

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P4-0127
Name:Farmacevtska biotehnologija: znanost za zdravje

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P3-0360
Name:Celostna obravnava alergijskih bolezni in astme v Sloveniji: od epidemiologije do genetike

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J3-50099
Name:Nov terapevtski pristop za zdravljenje alergijskih bolezni, ki temelji na inhibiciji interakcije med epitopi in paratopi

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back